Как победить диабет. Руководство по питанию и образу жизни

77. Newsholme P, Keane D, Welters HJ, Morgan NG. Life and death decisions of the pancreatic b-cell: the role of fatty acids. Clin Sci. 2007; 112(1): 27–42.

78. Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association. Circulation. 2017; 136(3): e1–e23.

79. U.S. Deparment of Agriculture. Agriculture Research Service. Nutrient Data Library. USDA National Nutrition Database for Standard Reference, Legacy Version Current: April 2018. URL: https://ndb.nal.usda.gov/ndb/search/list.

80. Fabricio G, Malta A, Chango A, De Freitas Mathias PC. Environmental contaminants and pancreatic beta-cells. J Clin Res Pediatr Endocrinol. 2016; 8(3): 257–263.

81. Magliano DJ, Loh VHY, Harding JL, et al. Persistent organic pollutants and diabetes: A review of the epidemiological evidence. Diabetes Metab. 2014; 40(1): 1–14.

82. EFSA. Cadmium dietary exposure. EFSA Journal. 2012; 10(1): 1–37.

83. Evangelou E, Ntritsos G, Chondrogiorgi M, et al. Exposure to pesticides and diabetes: A systematic review and meta-analysis. Environ Int. 2016; 91: 60–68.

84. Liu G, Zong G, Wu K, et al. Meat cooking methods and risk of type 2 diabetes: Results from three prospective cohort studies. Diabetes Care. 2018; 41(5): 1049–1060.

85. Stallings-Smith S, Mease A, Johnson TM, Arikawa AY. Exploring the association between polycyclic aromatic hydrocarbons and diabetes among adults in the United States. Environ Res. 2018; 166: 588–594.

86. Abdel-Shafy HI, Mansour MSM. A review on polycyclic aromatic hydrocarbons: Source, environmental impact, effect on human health and remediation. Egypt J Pet. 2016; 25(1): 107–123.

87. Vlassara H, Uribarri J. Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both? Curr Diab Rep. 2014; 14(1): 453.

88. Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015; 5(1): 194–222.

89. Velasquez MT, Ramezani A, Manal A, Raj DS. Trimethylamine n-oxide: The good, the bad and the unknown. Toxins (Basel). 2016; 8(11).

90. Janeiro M, Ramírez M, Milagro F, et al. Implication of trimethylamine n-oxide (tmao) in disease: Potential biomarker or new therapeutic target. Nutrients. 2018; 10(10): 1398.

91. Samraj AN, Pearce OMT, Läubli H, et al. A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci. 2015; 112(2): 542–547.

92. Alisson-Silva F, Kawanishi K, Varki A. Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid. Mol Aspects Med. 2016; 51: 16–30.

93. Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr. 2011; 105(01): 15–23.

94. Piya MK, Harte AL, McTernan PG. Metabolic endotoxaemia: Is it more than just a gut feeling? Curr Opin Lipidol. 2013; 24(1): 78–85.

95. Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013; 7(4): 880–884.

96. White D, Collinson A. Red meat, dietary heme iron, and risk of type 2 diabetes: The involvement of advanced lipoxidation endproducts. Adv Nutr. 2013; 4: 403–411.

97. Radzeviciene L, Ostrauskas R. Adding salt to meals as a risk factor of type 2 diabetes mellitus: A case-control study. Nutrients. 2017; 9(1): 67.

98. Horikawa C, Yoshimura Y, Kamada C, et al. Dietary sodium intake and incidence of diabetes complications in Japanese patients with type 2 diabetes: analysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab. 2014; 99(10): 3635–3643.

99. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013; 6: 327–338.

100. Suckling RJ, He FJ, Markandu ND, MacGregor GA. Modest salt reduction lowers blood pressure and albumin excretion in impaired glucose tolerance and type 2 diabetes mellitus. Hypertension. 2016; 67(6): 1189–1195.

101. Purohit V, Mishra S. The truth about artificial sweeteners – Are they good for diabetics? Indian Heart J. 2018; 70(1): 197–199.

102. Fagherazzi G, Gusto G, Affret A, et al. Chronic consumption of artificial sweetener in packets or tablets and type 2 diabetes risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study. Ann Nutr Metab. 2017; 70(1): 51–58.